Breast cancer patients who participated in a remote weight loss intervention program lost an average of 4.7% of their baseline body weight after one year, while those in the education only control ...
**NM signifies a non meaningful value. A dash signifies the data is not available.
The BWEL trial showed significant weight loss in the WLI group, suggesting potential benefits in reducing cancer recurrence and mortality. The trial involved 3180 women with stage II/III HER2-negative ...
Obesity has many adverse effects in patients with breast and other cancers. In this analysis, breast cancer patients randomized to a behavioral weight-loss intervention lost an average of 4.7% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results